|Bid||195.75 x 800|
|Ask||204.73 x 1100|
|Day's range||198.11 - 203.27|
|52-week range||139.59 - 336.99|
|Beta (5Y monthly)||1.47|
|PE ratio (TTM)||15.91|
|Earnings date||04 Nov 2021|
|Forward dividend & yield||5.68 (2.85%)|
|Ex-dividend date||20 Sep 2021|
|1y target est||363.33|
Medifast (MED) has long been gaining on the strength of its OPTAVIA lifestyle solution and coaching support system, while rising SG&A costs are a worry.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Medifast (MED) has been benefiting from its OPTAVIA lifestyle solution and coaching support system as well as focus on capacity expansion and technological advancements.